Back to Search
Start Over
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.
- Source :
-
Blood cancer journal [Blood Cancer J] 2021 Feb 01; Vol. 11 (2), pp. 27. Date of Electronic Publication: 2021 Feb 01. - Publication Year :
- 2021
- Subjects :
- Antineoplastic Agents pharmacology
Cell Line, Tumor
Humans
Karyopherins metabolism
Leukemia-Lymphoma, Adult T-Cell metabolism
Receptors, Cytoplasmic and Nuclear metabolism
Exportin 1 Protein
Apoptosis drug effects
Hydrazines pharmacology
Karyopherins antagonists & inhibitors
Leukemia-Lymphoma, Adult T-Cell drug therapy
Receptors, Cytoplasmic and Nuclear antagonists & inhibitors
Triazoles pharmacology
Tumor Suppressor Protein p53 metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 11
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Publication Type :
- Report
- Accession number :
- 33563902
- Full Text :
- https://doi.org/10.1038/s41408-021-00409-3